Professor, Medicine, Emory University School of Medicine
Infectious Disease
Dr. Mark J. Mulligan, MD
Mark J. Mulligan, MD is an expert in the field of Infectious Disease. He studied medicine at University of Alabama Medical Center. University of Alabama Medical Center has a rank of 37 in research and a 17 in primary care Mark J. Mulligan, MD is a published doctor as well. He has 84 publications published. The latest was: Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. He is registered with Medicare.
Publications
- Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
- Era of global Ebola: risk of exposure in health-care workers.
- Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons â¥18 Years Old.
- Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial.
- Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial.
- Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.
- Social Discrimination and Resiliency are not associated with Differences in Prevalent HIV Infection in Black and White Men who have Sex with Men.
- Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.
- Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles.
- Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
- Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.
- A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immuno...
- Detection of anti-yellow Fever virus immunoglobulin m antibodies at 3-4 years following yellow Fever vaccination.
- Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older perso...
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.
- Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation.
- An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.
- The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
- Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.
- Advances in human clinical trials of vaccines to prevent HIV/AIDS and other HIV prevention interventions.
- The imperative of influenza vaccines for elderly individuals-an evolving story.
- Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.
- Factors influencing HIV vaccine community engagement in the urban South.
- Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.
- Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?
- Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
- Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.
- Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals.
- T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles.
- Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities.
- Foamy virus envelope glycoprotein is sufficient for particle budding and release.
- Human immunodeficiency virus-specific CD8(+) T cells in human breast milk.
- Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.
- Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick.
- Understanding Racial HIV/STI Disparities in Black and White Men Who Have Sex with Men: A Multilevel Approach.
- Loa loa infection in temporary residents of endemic regions: recognition of a hyperresponsive syndrome with characteristic clinical manifestations.
- Using learning networks to understand complex systems: a case study of biological, geophysical and social research in the Amazon.
- Mark Mulligan leads Emory swine flu vaccine trial. Interview by Brooke Grindlinger.
- Neoplastic meningitis with eosinophilic pleocytosis in Hodgkin's disease: a case with cerebellar dysfunction and a review of the literature.
- Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group.
- Identification of an ER retrieval signal in a retroviral glycoprotein.
- HIV infection in vaccinated volunteers.
- Protection against vaginal SIV transmission with microencapsulated vaccine.
- A polarized human endometrial cell line that binds and transports polymeric IgA.
- Early acquisition of antibody to Plasmodium falciparum sporozoites in nonimmune temporary residents of Africa.
- Endogenous virus of BHK-21 cells complicates electron microscopy studies of foamy virus maturation.
- Human trials of HIV-1 vaccines.
- HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic.
- Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses.
- QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.
- Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Gr...
- Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.
- Retention of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum does not redirect virus assembly from the plasma membrane.
- Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
- Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
- Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain.
- Oligopeptide inhibitors of HIV-induced syncytium formation.
- Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types.
- Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain.
- The matrix protein of HIV-1 is not sufficient for assembly and release of virus-like particles.
- A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjects.
- Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
- A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte resp...
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.
- Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Cor...
- The env protein of an infectious noncytopathic HIV-2 is deficient in syncytium formation.
- Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.
- Analysis of west African hunters for foamy virus infections.
- An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes.
- Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env.
- Inhibition of human immunodeficiency virus type 1-induced cell fusion by recombinant human interferons.
- A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum.
- A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.
- Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group.
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.
- Excellent safety and tolerability of the human immunodeficiency virus type 1 pGA2/JS2 plasmid DNA priming vector vaccine in HIV type 1 uninfected adults.
- Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte ...
- Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents.
- CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
- Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial.
- Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.
- Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
- Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant.
Schools
University of Texas Southwestern Medical Center At Dallas
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
University of Alabama Medical Center -
University of Texas Southwestern Medical School
Hospital
-
Grady Memorial Hospital -
Emory University Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720019920 |
| Last Name Of The Provider | MULLIGAN |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Jacek Skarbinski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Henry M. Blumberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Paulina A. Rebolledo Esteinou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wendy S. Armstrong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alice Y. Guh, MD |
|
|
Dr. Nimalie D. Stone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Miwako Kobayashi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Monica E. Parise, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert M. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alicia I. Hidron, MD
This Doctor is OpenDoctor Recommended.
|